1 - Rapid onset of action from the first day

2- Superior efficacy as a monotherapy in partial onset seizures &remain seizure-free for at least 1 year 

3- Broad spectrum efficacy for all types of seizures as adjunctive therapy

 4 - No known clinically significant drug –drug interactions.

5- Long term favorable tolerability with no black box warning

 6- Excellent safety profile.